HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James N Kochenderfer Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2018Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James N Kochenderfer Research Topics

Disease

29Neoplasms (Cancer)
03/2024 - 12/2006
11Multiple Myeloma
01/2023 - 04/2013
8Lymphoma (Lymphomas)
11/2023 - 11/2010
6Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 04/2013
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 02/2015
5Leukemia
12/2017 - 09/2009
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2024 - 12/2013
3Cytokine Release Syndrome
12/2023 - 01/2016
3Infections
12/2021 - 12/2017
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 02/2015
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 03/2016
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2021 - 01/2018
2Graft vs Host Disease (Graft-Versus-Host Disease)
04/2016 - 03/2016
1Critical Illness (Critically Ill)
01/2022
1cell-associated neurotoxicity
01/2022
1Cytopenia
01/2022
1Fever (Fevers)
12/2021
1Neutropenia
12/2021
1Hodgkin Disease (Hodgkin's Disease)
01/2021
1Brain Edema (Cerebral Edema)
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
12/2017
1Pigmented Villonodular Synovitis
04/2016
1Neoplasm Metastasis (Metastasis)
04/2016
1Tumor Lysis Syndrome
12/2013
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2013
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2010
1Residual Neoplasm
07/2007
1Melanoma (Melanoma, Malignant)
12/2006

Drug/Important Bio-Agent (IBA)

35Chimeric Antigen ReceptorsIBA
03/2024 - 09/2009
10AntigensIBA
01/2023 - 07/2007
7bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2023 - 04/2013
6B-Cell Maturation AntigenIBA
01/2023 - 04/2013
6CytokinesIBA
01/2020 - 03/2012
4Proteins (Proteins, Gene)FDA Link
01/2023 - 12/2006
3axicabtagene ciloleucelIBA
01/2022 - 01/2019
3Interleukin-2 (IL2)IBA
08/2007 - 12/2006
3VaccinesIBA
08/2007 - 12/2006
2idecabtagene vicleucelIBA
01/2023 - 01/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021 - 01/2020
2Interleukin-15 (Interleukin 15)IBA
01/2018 - 06/2017
2EpitopesIBA
07/2007 - 12/2006
2Peptides (Polypeptides)IBA
07/2007 - 12/2006
1Biomarkers (Surrogate Marker)IBA
12/2023
1fludarabineIBA
11/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023
1tocilizumab (atlizumab)FDA Link
12/2021
1remdesivirIBA
10/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1LigandsIBA
01/2019
1tisagenlecleucelIBA
01/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
12/2017
1Therapeutic UsesIBA
12/2017
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2016
1InterleukinsIBA
03/2016
1Interleukin-6 (Interleukin 6)IBA
03/2016
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2016
1crisamicin AIBA
01/2016
1CD19 AntigensIBA
11/2010
1AutoantigensIBA
11/2010
1Trastuzumab (Herceptin)FDA Link
11/2009
1Muromonab-CD3 (Muromonab CD3)FDA Link
09/2009
1CPG-oligonucleotideIBA
12/2006
1OligodeoxyribonucleotidesIBA
12/2006
1Monophenol Monooxygenase (Tyrosinase)IBA
12/2006

Therapy/Procedure

19Therapeutics
03/2024 - 11/2010
7Drug Therapy (Chemotherapy)
01/2023 - 11/2010
6Immunotherapy
01/2019 - 11/2011
3Hematopoietic Stem Cell Transplantation
04/2016 - 12/2013
2Aftercare (After-Treatment)
01/2018 - 12/2013
2Stem Cell Transplantation
06/2017 - 07/2007
1Resuscitation
01/2020
1Antibiotic Prophylaxis
12/2017
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2011